blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1001816

EP1001816 - PERFLUORINATED-ETHER COMPOSITIONS AS DIAGNOSTIC CONTRAST AGENTS [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  04.04.2003
Database last updated on 20.07.2024
Most recent event   Tooltip04.04.2003Withdrawal of applicationpublished on 21.05.2003  [2003/21]
Applicant(s)For all designated states
IMARX PHARMACEUTICAL CORP.
1635 East 18th Street
Tucson, AZ 85719 / US
[2000/21]
Inventor(s)01 / UNGER, evan, C.
13365 E. Camino LaCebadilla
Tucson, AZ 85749 / US
[2000/21]
Representative(s)James, Anthony Christopher W.P., et al
Carpmaels & Ransford LLP
One Southampton Row
London
WC1B 5HA / GB
[N/P]
Former [2000/21]James, Anthony Christopher W.P., et al
Carpmaels & Ransford 43 Bloomsbury Square
London WC1A 2RA / GB
Application number, filing date97946447.603.11.1997
[2000/21]
WO1997US19900
Priority number, dateUS19960031903P25.11.1996         Original published format: US 31903 P
US1997080099320.02.1997         Original published format: US 800993
[2000/21]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9823298
Date:04.06.1998
Language:EN
[1998/22]
Type: A1 Application with search report 
No.:EP1001816
Date:24.05.2000
Language:EN
The application published by WIPO in one of the EPO official languages on 04.06.1998 takes the place of the publication of the European patent application.
[2000/21]
Search report(s)International search report - published on:US04.06.1998
(Supplementary) European search report - dispatched on:EP28.05.2002
ClassificationIPC:A61K49/04, C07C41/00, C07C19/08, A61K47/48
[2002/17]
CPC:
A61K49/223 (EP)
Former IPC [2000/21]A61K49/04, C07C41/00, C07C19/08
Designated contracting statesDE,   FR,   GB,   IT [2000/21]
TitleGerman:PERFLUORIETE ETHERN ZUSAMMENSETZUNGEN WIE KONTRASTMITTEL[2000/21]
English:PERFLUORINATED-ETHER COMPOSITIONS AS DIAGNOSTIC CONTRAST AGENTS[2000/21]
French:COMPOSITIONS D'ETHER PERFLUORE UTILISEES COMME AGENTS DE CONTRASTE DIAGNOSTIQUES[2000/21]
Entry into regional phase18.06.1999National basic fee paid 
18.06.1999Search fee paid 
18.06.1999Designation fee(s) paid 
18.06.1999Examination fee paid 
Examination procedure10.06.1998Request for preliminary examination filed
International Preliminary Examining Authority: US
18.06.1999Examination requested  [2000/21]
21.03.2003Application withdrawn by applicant  [2003/21]
Fees paidRenewal fee
18.06.1999Renewal fee patent year 03
28.11.2000Renewal fee patent year 04
14.11.2001Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
30.11.200206   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO9631196  (IMARX PHARMACEUTICAL CORP) [X] 1-17,24-62,64,66-69 * page 23, line 20 - page 24, line 8; claims 3-8,17,18,35,36,46 *;
 [X]WO9531965  (MINNESOTA MINING & MFG) [X] 1-17,24-62,64,66-69 * abstract * * page 8 - page 11 * * page 14, lines 1-5; claims 16,22,30; table 1 *;
 [PX]WO9640281  (WEERS JEFFRY GREG ;ALLIANCE PHARMA (US); KABALNOV ALEXEY (US); SCH) [PX] 1-17,24-62,64,66-69 * abstract *;
 [E]WO9842384  (IMARX PHARMACEUTICAL CORP) [E] 1-17,24-62,64,66-69 * page 56, lines 12-15; examples 2,5,9; claims 2,3,11,18-25,35,52-54,61-64 *;
 [A]US5350571  (KAUFMAN ROBERT J ET AL) [A] 1-17,24-62,64,66-69 * abstract * * column 6, lines 31-49 *;
 [E]WO9804292  (ACUSPHERE INC) [E] 1-17,24-62,64,66-69 * abstract *
International search[Y]US5498421  ;
 [Y]US5501863  ;
 [Y]US5350571  ;
 [Y]US5502094
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.